Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Thyroid Diseases × tomivosertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Dermatologic 1

Conditions

Triple Negative Breast Neoplasms 1 Thyroid Diseases 1 Solid Tumors 1 Prostatic Neoplasms 1 Neoplasms 1 Melanoma 1 Lymphoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

selpercatinib 2 tomivosertib 1 repotrectinib 1 pralsetinib 1 Vitamin B 12 1 Surgical Procedures, Operative 1 Pemetrexed 1 Folic Acid 1 Cisplatin 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02605083 2020-11-02

A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors

Effector Therapeutics

Phase 1/2 Terminated

DermatologicHead & Neck

Melanoma, Neoplasms, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡